Makiko Yasuda

2.9k citations

42 papers · 2.1k indexed · 1 hit paper · h-index 19

Co-authors: Robert J. Desnick Hitoshi Sakuraba Marco Spada Turgut Tükel Severo Pagliardini Alberto Ponzone Geetha Thiagarajan Junaid Shabbeer
Topics: Porphyrin Metabolism and Disorders (25 papers)Heme Oxygenase-1 and Carbon Monoxide (21 papers)Lysosomal Storage Disorders Research (13 papers)
Cited by: Physiology Rheumatology Cell Biology
Journals: Science Proceedings of the National Academy of Sciences Blood
Partner nations: United States Japan Austria

In The Last Decade

Makiko Yasuda

42 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*

2006 713 citations Makiko Yasuda, Robert J. Desnick et al. The American Journal of Human Genetics profile →

Peers

Countries citing papers authored by Makiko Yasuda

Since Specialization

Citations

This map shows the geographic impact of Makiko Yasuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makiko Yasuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makiko Yasuda more than expected).

Fields of papers citing papers by Makiko Yasuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makiko Yasuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makiko Yasuda. The network helps show where Makiko Yasuda may publish in the future.

Co-authorship network of co-authors of Makiko Yasuda

This figure shows the co-authorship network connecting the top 25 collaborators of Makiko Yasuda. A scholar is included among the top collaborators of Makiko Yasuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makiko Yasuda. Makiko Yasuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Endocannabinoid receptor 2 is a potential biomarker and therapeutic target for the lysosomal storage disorders 2024 ·Journal of Inherited Metabolic Disease ·Calogera M. Simonaro,Makiko Yasuda,Edward H. Schuchman	1
2	Case‐based discussion of the acute hepatic porphyrias: Updates on pathogenesis, diagnosis and management 2024 ·Liver International ·Manisha Balwani,Sioḃán Keel,Peter N. Meissner,Mark Sonderup,Penelope E. Stein,Makiko Yasuda	1
3	Cimetidine Does Not Inhibit 5-Aminolevulinic Acid Synthase or Heme Oxygenase Activity: Implications for Treatment of Acute Intermittent Porphyria and Erythropoietic Protoporphyria 2023 ·Biomolecules ·Makiko Yasuda,Sang Mi Lee,Lin Gan,Hector A. Bergonia,Robert J. Desnick,John D. Phillips	7
4	RNA interference therapy in acute hepatic porphyrias 2023 ·Blood ·Makiko Yasuda,Sioḃán Keel,Manisha Balwani	10
5	ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic α-Gal A activity and effective substrate reduction in Fabry mice 2021 ·Molecular Therapy ·Silvère Pagant,(unknown),Luciana Moreira,Lin Gan,Susan S. Martin,Scott Sproul,Michael C. Holmes,Kathleen Meyer,Thomas Wechsler,Robert J. Desnick,Makiko Yasuda	13
6	AAV2/6 Gene Therapy in a Murine Model of Fabry Disease Results in Supraphysiological Enzyme Activity and Effective Substrate Reduction 2020 ·Molecular Therapy — Methods & Clinical Development ·Makiko Yasuda,(unknown),Silvère Pagant,Lin Gan,Susan S. Martin,Scott Sproul,Daniel A. Richards,Stephen J. Ballaron,(unknown),Annemarie Ledeboer,(unknown),(unknown),Yanmei Lu,Michael C. Holmes,Kathleen Meyer,Robert J. Desnick,Thomas Wechsler	41
7	Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies 2019 ·Molecular Genetics and Metabolism ·Makiko Yasuda,Robert J. Desnick	13
8	Characterization of the hepatic transcriptome following phenobarbital induction in mice with AIP 2019 ·Molecular Genetics and Metabolism ·Brenden Chen,Minghui Wang,Lin Gan,Bin Zhang,Robert J. Desnick,Makiko Yasuda	8
9	Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations 2018 ·Molecular Genetics and Metabolism ·(unknown),Brenden Chen,Makiko Yasuda,Irina Nazarenko,Karl E. Anderson,Robert J. Desnick	5
10	Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes 2018 ·Molecular Genetics and Metabolism ·Makiko Yasuda,Brenden Chen,Robert J. Desnick	49
11	Acute hepatic porphyrias: Identification of 46 hydroxymethylbilane synthase, 11 coproporphyrinogen oxidase, and 20 protoporphyrinogen oxidase novel mutations 2018 ·Molecular Genetics and Metabolism ·(unknown),Makiko Yasuda,Brenden Chen,Irina Nazarenko,Neal Cody,Robert J. Desnick	2
12	Acute Intermittent Porphyria in children: A case report and review of the literature 2016 ·Molecular Genetics and Metabolism ·Manisha Balwani,Preeti Singh,Anju Seth,(unknown),Hetanshi Naik,Dana Doheny,Brenden Chen,Makiko Yasuda,Robert J. Desnick	24
13	Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver 2015 ·Molecular Medicine ·Makiko Yasuda,Angelika Erwin,Lawrence U. Liu,Manisha Balwani,Brenden Chen,(unknown),Lin Gan,Maria Isabel Fiel,Ronald E. Gordon,Chunli Yu,Sonia Clavero,Antonios Arvelakis,Hetanshi Naik,(unknown),John D. Phillips,Karl E. Anderson,(unknown),Sander Florman,Robert J. Desnick	44
14	Loss-of-Function Ferrochelatase and Gain-of-Function Erythroid-Specific 5-Aminolevulinate Synthase Mutations Causing Erythropoietic Protoporphyria and X-Linked Protoporphyria in North American Patients Reveal Novel Mutations and a High Prevalence of X-Linked Protoporphyria 2013 ·Molecular Medicine ·Manisha Balwani,Dana Doheny,David F. Bishop,Irina Nazarenko,Makiko Yasuda,Harry A. Dailey,Karl E. Anderson,D. Montgomery Bissell,Joseph R. Bloomer,Herbert L. Bonkovsky,John D. Phillips,Lawrence Liu,Robert J. Desnick	69
15	A LC–MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen 2011 ·Journal of Chromatography B ·Jinglan Zhang,Makiko Yasuda,Robert J. Desnick,Manisha Balwani,David F. Bishop,Chunli Yu	39
16	AAV8-mediated Gene Therapy Prevents Induced Biochemical Attacks of Acute Intermittent Porphyria and Improves Neuromotor Function 2009 ·Molecular Therapy ·Makiko Yasuda,David F. Bishop,Mary Fowkes,Seng H. Cheng,Lin Gan,Robert J. Desnick	41
17	Fabry disease: Identification of 50 novel α-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations 2006 ·Human Genomics ·Junaid Shabbeer,Makiko Yasuda,Stacy D. Benson,Robert J. Desnick	117
18	Uroporphyrinogen III Synthase Knock-In Mice Have the Human Congenital Erythropoietic Porphyria Phenotype, Including the Characteristic Light-Induced Cutaneous Lesions 2006 ·The American Journal of Human Genetics ·David F. Bishop,Annika Johansson,Robert Phelps,(unknown),Maria Celeste M. Ramirez,Makiko Yasuda,Andrés Caro,Robert J. Desnick	17
19	Fabry Disease: Novel α-Galactosidase A 3′-Terminal Mutations Result in Multiple Transcripts Due to Aberrant 3′-End Formation 2003 ·The American Journal of Human Genetics ·Makiko Yasuda,Junaid Shabbeer,Makiko Ōsawa,Robert J. Desnick	35
20	Fabry disease: twenty novel α-galactosidase A mutations causing the classical phenotype 2001 ·Journal of Human Genetics ·Grace A. Ashley,Junaid Shabbeer,Makiko Yasuda,Christine M. Eng,Robert J. Desnick	52

About Makiko Yasuda

Makiko Yasuda is a scholar working on Rheumatology, Physiology and Molecular Biology, having authored 42 papers that have together received 2.1k indexed citations. Recurring topics across this work include Porphyrin Metabolism and Disorders (25 papers), Heme Oxygenase-1 and Carbon Monoxide (21 papers) and Lysosomal Storage Disorders Research (13 papers). The work is most often cited by research in Physiology (1.2k citations), Rheumatology (504 citations) and Cell Biology (362 citations). Makiko Yasuda has collaborated with scholars based in United States, Japan and Austria. Frequent co-authors include Robert J. Desnick, Hitoshi Sakuraba, Marco Spada, Turgut Tükel, Severo Pagliardini, Alberto Ponzone, Geetha Thiagarajan, Junaid Shabbeer, Brenden Chen and Stacy D. Benson. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact